Bariatric and metabolic surgery (BMS) is the most effective treatment for obesity, type 2
diabetes (T2D) and comorbidities, including nonalcoholic fatty liver disease (NAFLD) and …

Bariatric surgeries induce marked and durable weight loss in individuals with morbid obesity
through powerful effects on both food intake and energy expenditure. While alterations in gut …

Bariatric surgery is a sustainable weight loss approach, including vertical sleeve
gastrectomy (VSG). Obesity exacerbates tumor growth, while diet-induced weight loss …

Objective To characterize longitudinal changes in blood biomarkers, leukocyte composition,
and gene expression following laparoscopic sleeve gastrectomy (LSG). Background LSG is …

DNA methylation is dynamically regulated in metabolic diseases, but it remains unclear
whether the changes are causal or consequential. Therefore, we used a longitudinal …

Background Bariatric surgery is associated with a positive effect on the progress of non-
alcoholic associated fatty liver disease (NAFLD). Although weight loss is the obvious …

Objective Bariatric surgery remains the only effective and durable treatment option for
morbid obesity. Vertical Sleeve Gastrectomy (VSG) is currently the most widely performed of …

Purpose Obesity exerts negative effects on pulmonary function through proven mechanical
and biochemical pathways. Multiple studies have suggested that bariatric surgery can …

Obesity is a rising medical condition; metabolic and bariatric surgery, mainly sleeve
gastrectomy, offers a successful weight loss option which is maintainable. Weight loss is …

Objective Sleeve gastrectomy (SG) has profound, immediate weight-loss independent
effects on obesity related diabetes (T2D). Our prior studies have shown that immunologic …